Publications by authors named "Yaneisi Palou Martinez"
Article Synopsis
- Traumatic brain injury (TBI) often leads to long-term mood disorders, which are a significant concern as highlighted in recent research.
- The systematic review examines studies from the past decade, exploring the connections between TBI and mood disorders in individuals aged 12 to 60 years and older.
- By analyzing epidemiological trends, neurobiological factors, and psychosocial influences, the review aims to improve understanding and management of this common yet overlooked issue.
Sickle cell disease (SCD) is a group of inherited genetic disorders that is caused by a mutation in the gene that codes for hemoglobin subunit β. This systematic review aimed to evaluate the effect of folic acid in the treatment of SCD patients. We retrieved 3730 articles from PubMed, PubMed Central, Google Scholar, and ScienceDirect databases.
View Article and Find Full Text PDFEtanercept (ETN) is a disease-modifying anti-rheumatic drug (DMARD) used in the treatment of rheumatoid arthritis (RA) that works as a tumor necrosis factor inhibitor (TNF inhibitor) by blocking the effects of naturally occurring TNF. This review will evaluate the effect of ETN as a monotherapy or combination therapy with methotrexate (MTX) in the treatment of RA. This systematic review was carried out in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 guidelines.
View Article and Find Full Text PDFArticle Synopsis
- Gender-affirming hormonal therapy (GAHT) is used by transgender individuals to align their physical characteristics with their gender identity, but it may increase the risk of metabolic issues, including a potential rise in type 2 diabetes mellitus.
- This study systematically reviewed literature from 2014 to 2024, analyzing 11 articles on body mass index (BMI), insulin resistance, and diabetes incidence in both cisgender and transgender individuals undergoing GAHT.
- Results indicated that while there wasn't clear evidence of increased diabetes incidence among GAHT patients, there was a notable rise in BMI and insulin resistance, particularly in transgender women, suggesting the need for regular monitoring during treatment and further research to explore these metabolic effects.